Redhill Biopharma Stock Market Value
| RDHL Stock | USD 7.96 0.05 0.63% |
| Symbol | Redhill |
Redhill Biopharma Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (302.63) | Revenue Per Share 4.733 | Quarterly Revenue Growth (0.28) | Return On Assets (0.45) | Return On Equity (17.09) |
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Redhill Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Redhill Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Redhill Biopharma.
| 08/30/2024 |
| 11/28/2024 |
If you would invest 0.00 in Redhill Biopharma on August 30, 2024 and sell it all today you would earn a total of 0.00 from holding Redhill Biopharma or generate 0.0% return on investment in Redhill Biopharma over 90 days. Redhill Biopharma is related to or competes with Organogenesis Holdings, Lifecore Biomedical, Collegium Pharmaceutical, Aquestive Therapeutics, Evoke Pharma, Petros Pharmaceuticals, and Cumberland Pharmaceuticals. RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious dise... More
Redhill Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Redhill Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Redhill Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.11 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 29.17 | |||
| Value At Risk | (7.40) | |||
| Potential Upside | 9.81 |
Redhill Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Redhill Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Redhill Biopharma's standard deviation. In reality, there are many statistical measures that can use Redhill Biopharma historical prices to predict the future Redhill Biopharma's volatility.| Risk Adjusted Performance | 0.0125 | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.78) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0223 |
Redhill Biopharma Backtested Returns
As of now, Redhill Stock is somewhat reliable. Redhill Biopharma maintains Sharpe Ratio (i.e., Efficiency) of 0.0013, which implies the firm had a 0.0013% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Redhill Biopharma, which you can use to evaluate the volatility of the company. Please check Redhill Biopharma's Risk Adjusted Performance of 0.0125, semi deviation of 4.06, and Coefficient Of Variation of 19053.77 to confirm if the risk estimate we provide is consistent with the expected return of 0.0064%. The company holds a Beta of 0.74, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Redhill Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Redhill Biopharma is expected to be smaller as well. Redhill Biopharma right now holds a risk of 4.78%. Please check Redhill Biopharma jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to decide if Redhill Biopharma will be following its historical price patterns.
Auto-correlation | 0.65 |
Good predictability
Redhill Biopharma has good predictability. Overlapping area represents the amount of predictability between Redhill Biopharma time series from 30th of August 2024 to 14th of October 2024 and 14th of October 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Redhill Biopharma price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current Redhill Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.65 | |
| Spearman Rank Test | 0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 0.39 |
Redhill Biopharma lagged returns against current returns
Autocorrelation, which is Redhill Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Redhill Biopharma's stock expected returns. We can calculate the autocorrelation of Redhill Biopharma returns to help us make a trade decision. For example, suppose you find that Redhill Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Redhill Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Redhill Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Redhill Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Redhill Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Redhill Biopharma Lagged Returns
When evaluating Redhill Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Redhill Biopharma stock have on its future price. Redhill Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Redhill Biopharma autocorrelation shows the relationship between Redhill Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Redhill Biopharma.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Redhill Biopharma Correlation, Redhill Biopharma Volatility and Redhill Biopharma Alpha and Beta module to complement your research on Redhill Biopharma. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Redhill Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.